Revolution Medicines Inc
F:42Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Revolution Medicines Inc
F:42Z
|
US |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
|
Lime Technologies AB (publ)
STO:LIME
|
SE |
|
Diebold Nixdorf Inc
NYSE:DBD
|
US |
|
N
|
National Storage Affiliates Trust
F:4GC
|
US |
|
A
|
Air Products and Chemicals Inc
SWB:AP3
|
US |
|
C
|
Cleveland-Cliffs Inc
BMV:CLF
|
US |
|
Pultegroup Inc
NYSE:PHM
|
US |
Wall St Price Targets
42Z Price Targets Summary
Revolution Medicines Inc
According to Wall Street analysts, the average 1-year price target for
42Z is 51.6 EUR with a low forecast of 37.34 EUR and a high forecast of 69.4 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 42Z's stock price target?
Price Target
51.6
EUR
According to Wall Street analysts, the average 1-year price target for
42Z is 51.6 EUR with a low forecast of 37.34 EUR and a high forecast of 69.4 EUR.